Abstract: The present disclosure provides a rod-type pile foundation for preventing a pile body from being heaved and an operating method. The rod-type pile foundation comprises a base, a support block fixed inside the base, a support plate movably disposed at a top of the support block by a guide structure, and an anti-frost heaving component located at a lower portion of the support block. The anti-frost heaving component includes a first connecting rod rotationally connected with the support block and one or more telescopic rods. One end of each of the telescopic rods is fixed on the first connecting rod. A scraping plate is fixed at another end of each of the telescopic rods. The support plate is in transmission connection with the first connecting rod through a transmission component. The transmission component converts a vertical linear motion of the support plate into a rotation of the first connecting rod.

Abstract: The present invention broadly relates to a process for preparing products comprising active components, and in particular biological materials, wherein the active components are stabilised. The invention further relates to compositions comprising the products, and in particular compositions comprising therapeutic biological materials.

Abstract: Provided herein are methods for the treatment of abnormal inflammation and inflammatory conditions comprising mucosal administration of an effective amount of an interleukin (e.g. IL-2) or a fragment or derivative thereof. Also provided herein are pharmaceutical compositions for mucosal administration for the treatment of abnormal inflammation and inflammatory conditions, the composition comprising said interleukin or fragment or derivative.

Abstract: Provided herein are methods for the treatment of abnormal inflammation and inflammatory conditions comprising mucosal administration of an effective amount of an interleukin (e.g. IL-2) or a fragment or derivative thereof. Also provided herein are pharmaceutical compositions for mucosal administration for the treatment of abnormal inflammation and inflammatory conditions, the composition comprising said interleukin or fragment or derivative.

Abstract: The present invention broadly relates to a process for preparing products comprising active components, and in particular biological materials, wherein the active components are stabilised. The invention further relates to compositions comprising the products, and in particular compositions comprising therapeutic biological materials.

Abstract: The present invention broadly relates to a process for preparing products comprising active components, and in particular biological materials, wherein the active components are stabilized. The invention further relates to compositions comprising the products, and in particular compositions comprising therapeutic biological materials.

Abstract: Provided herein are methods for the treatment of abnormal inflammation and inflammatory conditions comprising mucosal administration of an effective amount of an interleukin (e.g. IL-2) or a fragment or derivative thereof. Also provided herein are pharmaceutical compositions for mucosal administration for the treatment of abnormal inflammation and inflammatory conditions, the composition comprising said interleukin or fragment or derivative.

Abstract: The present invention broadly relates to a process for preparing products comprising active components, and in particular biological materials, wherein the active components are stabilised. The invention further relates to compositions comprising the products, and in particular compositions comprising therapeutic biological materials.

Abstract: Programmable integrated Digital Satellite Equipment Control (DiSEqC) transceiver. The DiSEqC functionality is integrated onto a semiconductor device. Rather than perform the DiSEqC protocol in software, the DiSEqC protocol is implemented in hardware thereby providing more reliable demodulation and improved robustness. The device's functionality may employ much more reliable communication schemes that are enabled by the hardware/integrated approach of implementing the DiSEqC protocol. The integrated approach allows extensive programmability of the various operational parameters thereby greatly improving the ease of future backward compatibility with legacy devices; devices employing this integrated DiSEqC functionality may be easily updated to conform to future enhancements of the DiSEqC protocol.

Abstract: Non-aerosol spray-on skin patch compositions as described comprising at least one substantially water insoluble film forming agent, at least one film plasticizer agent, at least one water soluble compound, and at least one organic solvent, the composition forming a flexible, porous and physiologically compatible skin patch when sprayed on to skin and allowed to dry. Also described are methods of improving wound healing by administering a physiologically active ingredient to a patient in need of such treatment.

Abstract: Programmable integrated Digital Satellite Equipment Control (DiSEqC) transceiver. The DiSEqC functionality is integrated onto a semiconductor device. Rather than perform the DiSEqC protocol in software, the DiSEqC protocol is implemented in hardware thereby providing more reliable demodulation and improved robustness. The device's functionality may employ much more reliable communication schemes that are enabled by the hardware/integrated approach of implementing the DiSEqC protocol. The integrated approach allows extensive programmability of the various operational parameters thereby greatly improving the ease of future backward compatibility with legacy devices; devices employing this integrated DiSEqC functionality may be easily updated to conform to future enhancements of the DiSEqC protocol.

Abstract: A growth promotant comprising microgranules having a core consisting of one or more enzymes selected from: i) protein digesting enzymes; ii) carbohydrate digesting enzymes; iii) fat digesting enzymes; and iv) fiber digesting enzymes in an immobilized form; the core being encapsulated within a water soluble film, and coated with an enteric coating comprising an alkali soluble, acid insoluble polymer, or a high molecular weight polymer whose structure is substituted with or contains windows of fatty acid or other material capable of being solubilized by intestinal juices. A method for increasing animal growth comprising the administration of a growth promoting amount of the growth promotant is also described, as is a method of producing the growth promotant.